Platelet Rich Plasma Market is Projected to Expand at a CAGR of 12.0% from 2018 to 2026
Platelet-rich Plasma Market – Overview
This report studies the current as well as future prospects of the global platelet-rich plasma market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of platelet-rich plasma and new entrants planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the global platelet-rich plasma market regarding leading segments based on type, origin, application, and region.
The global platelet-rich plasma market has been segmented based on type, origin, application, and region. In terms of type, the global market has been classified into pure platelet-rich plasma, leukocyte-rich platelet-rich plasma, and pure platelet-rich fibrin. Based on origin, the global platelet-rich plasma market has been categorized into autologous platelet-rich plasma, allogeneic platelet-rich plasma, and homologous platelet-rich plasma. In terms of application, the global market has been divided into orthopedic surgery, neurosurgery, cosmetic surgery, general surgery, and others.
The market revenue for each type was estimated using bottom-up approach. The revenue generated by each type and application has been calculated considering sales, usage data, and pattern in different regions. The bottom-up approach for determining the country market size was studied using various market indicators obtained from secondary sources, which include different types and origin of platelet-rich plasma and their cost variations in major country/region; prevalence and incidence in major countries for orthopedic disorders, sports injuries, arthritis, and other major diseases, and other treatments such as cosmetic surgeries and plastic surgeries for which platelet-rich plasma are used. Revenues of all publicly listed market players were obtained through secondary sources and analyzed for platelet-rich plasma systems specific revenues by narrowing down to revenue percentage for product segment through extensive secondary analysis of annual reports, investor presentations, press releases, primary interviews, and others. Data triangulation is based on secondary research (top-down and bottom-up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each segment for the forecast period from 2018 to 2026, considering 2017 as the base year.
Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4021
The market overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have a strong impact on the platelet-rich plasma market and could influence it in the near future. Market attractiveness analysis has been provided to explain the intensity of competition across different regions. The competitive scenario among different players is evaluated through market share analysis in the competitive landscape section of the report. These factors are likely to help market players take strategic decisions to strengthen their positions and expand their shares in the global platelet-rich plasma market.
In terms of region, the global platelet-rich plasma market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries with each product and distribution channel in the respective region. A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the overview section. This section of the report also provides the market attractiveness analysis and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global platelet-rich plasma market.
Major players operating in the global platelet-rich plasma market are Harvest Technologies Corp. (Terumo Corporation), Arthrex, Inc., Zimmer Biomet Holdings, Inc., EmCyte Corporation, Regen Lab SA, Exactech, Inc., and Cesca Therapeutics, Inc., Nuo Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), ISTO Biologics, and AdiStem Ltd.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Email: [email protected]